What is Caris Life Sciences, Inc. Common Stock's share price today?
Caris Life Sciences, Inc. Common Stock (CAI) share price today is $32.89 as of November 5, 2026 at 2:19 AM IST. The stock touched a day high of $34.00 and a day low of $31.99.What exchange does Caris Life Sciences, Inc. Common Stock stock trade on, and under what ticker symbol?
Caris Life Sciences, Inc. Common Stock stock trades on NASDAQ under the ticker symbol CAI.What is Caris Life Sciences, Inc. Common Stock's market capitalization?
Caris Life Sciences, Inc. Common Stock's market capitalization is $9.07B as of November 5, 2026 at 2:19 AM IST.What is Caris Life Sciences, Inc. Common Stock's price-to-earnings (P/E) ratio?
Caris Life Sciences, Inc. Common Stock's price-to-earnings (P/E) ratio is 18.99 as of November 4, 2026.What is Caris Life Sciences, Inc. Common Stock's price-to-book (P/B) ratio?
Caris Life Sciences, Inc. Common Stock's price-to-book (P/B) ratio is 16.39 as of November 4, 2026.Can Indian investors buy Caris Life Sciences, Inc. Common Stock shares?
Yes, You can buy Caris Life Sciences, Inc. Common Stock shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Caris Life Sciences, Inc. Common Stock shares from India?
Indian investors can buy Caris Life Sciences, Inc. Common Stock shares in three steps: 1. Search Caris Life Sciences, Inc. Common Stock on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Caris Life Sciences, Inc. Common Stock shares for Indian investors?
Since Caris Life Sciences, Inc. Common Stock trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Caris Life Sciences, Inc. Common Stock shares via Tickertape?
Indian investors can start investing in Caris Life Sciences, Inc. Common Stock (CAI) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.304 shares at the current price of $32.89.
$
₹
$32.890.13% (+0.04)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
18.99
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
16.39
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$1.69
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
10.62%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Based on 14 analysts reports
Buy10 analysts
Hold4 analysts
Sell0 analyst
Price Upside
+1.13%
Earnings Growth
+112.55%
Rev. Growth
+26.84%
Company Profile
Company Profile
P/E Ratio
36.00
36.00
1Y Return
23.62%
23.62%
Buy Reco %
85.18
85.18
P/E Ratio
34.46
34.46
1Y Return
18.86%
18.86%
Buy Reco %
68.18
68.18
P/E Ratio
113.80
113.80
1Y Return
33.07%
33.07%
Buy Reco %
78.26
78.26
P/E Ratio
31.29
31.29
1Y Return
22.77%
22.77%
Buy Reco %
90.00
90.00
ILMN
P/E Ratio
38.99
38.99
1Y Return
98.52%
98.52%
Buy Reco %
47.61
47.61
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
2026
Current$32.1Baseline
Analyst Target - 1 year
Target$32.46+1.13%
All values in $
2026
Current$32.1Baseline
Analyst Target - 1 year
Target$32.46+1.13%
All values in $
Revenue Forecast
Revenue Forecast
2025
Current$812.03Baseline
Forecast for Dec 2026
High$1,036+27.58%
Average$1,029.96+26.84%
Low$1,004.2+23.66%
All values in $ Million
2025
Current$812.03Baseline
Forecast for Dec 2026
High$1,036+27.58%
Average$1,029.96+26.84%
Low$1,004.2+23.66%
All values in $ Million
Earnings Per Share Forecast
Earnings Per Share Forecast
2025
Current$-1.1Baseline
Forecast for Dec 2026
High$0.26+123.96%
Average$0.14+112.55%
Low$0.04+103.64%
All values in $
2025
Current$-1.1Baseline
Forecast for Dec 2026
High$0.26+123.96%
Average$0.14+112.55%
Low$0.04+103.64%
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 80.67 | 100.04 | 101.62 | 129.91 | 120.91 | 181.39 | 216.83 | 292.88 | 216.17 | 263.71 |
Gross Profit | 26.11 | 37.55 | 44.41 | 70.70 | 57.06 | 113.68 | 147.50 | 220.91 | 141.34 | 179.59 |
| Net Income | -111.02 | -66.18 | -67.72 | -36.94 | -102.58 | -71.79 | 24.32 | 81.95 | -0.51 | -0.63 |
| Net Profit Margin | -137.62% | -66.15% | -66.64% | -28.43% | -84.83% | -39.57% | 11.21% | 27.98% | -0.23% | -0.24% |
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
HealthcareBiotechnology
HealthcareBiotechnology
Valuation
Returns
Forecast
Compare valuation on Screener| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Caris Life Sciences, Inc. Common Stock | 18.99 | 16.39 | - |
| Thermo Fisher Scientific Inc | 36.00 | 4.71 | 2.03 |
| Agilent Technologies Inc | 34.46 | 6.69 | 1.48 |
Price Comparison
Price Comparison
Compare CAI with any stock or ETFCompare CAI with any stock or ETF
Comparing from
CAI
TMO
A
The next fiscal year's mean estimate implies 26.84% growth, versus a trailing 3-year CAGR of 46.46%.